{"transactions":[{"id":691872,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:32:03.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001193125-26-343067","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343067/ownership.xml","form_type":"4"}},{"id":691871,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T01:32:03.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001193125-26-343067","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343067/ownership.xml","form_type":"4"}},{"id":1071377,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:31:19.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":7200,"derivative":{"underlying":"Common Stock","underlying_shares":7200},"source":{"system":"sec-edgar","filing":"0000950170-25-105919","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025105919/ownership.xml","form_type":"4"}},{"id":1084039,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-07-21T20:42:49.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0000950170-25-097280","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097280/ownership.xml","form_type":"4"}},{"id":1084038,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-21T20:42:49.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":true,"shares":1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0000950170-25-097280","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097280/ownership.xml","form_type":"4"}},{"id":1451198,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-07-19T20:31:30.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":925,"derivative":{"underlying":"Common Stock","underlying_shares":925},"source":{"system":"sec-edgar","filing":"0000950170-24-084946","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024084946/ownership.xml","form_type":"4"}},{"id":1495154,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-03T20:58:36.000Z","date":"2024-06-02","kind":"exercise","planned":false,"acquired":false,"shares":81,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":81},"source":{"system":"sec-edgar","filing":"0000950170-24-068068","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068068/ownership.xml","form_type":"4"}},{"id":1495153,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-03T20:58:36.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":false,"shares":7,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7},"source":{"system":"sec-edgar","filing":"0000950170-24-068068","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068068/ownership.xml","form_type":"4"}},{"id":1495152,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T20:58:36.000Z","date":"2024-06-02","kind":"exercise","planned":false,"acquired":true,"shares":81,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":198,"source":{"system":"sec-edgar","filing":"0000950170-24-068068","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068068/ownership.xml","form_type":"4"}},{"id":1495151,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T20:58:36.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":true,"shares":7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":117,"source":{"system":"sec-edgar","filing":"0000950170-24-068068","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068068/ownership.xml","form_type":"4"}},{"id":1810876,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-08-10T20:10:17.000Z","date":"2023-08-09","kind":"exercise","planned":false,"acquired":false,"shares":3571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 3,571 RSUs, vesting in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 3,571 RSUs, vesting in full on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001209191-23-045303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123045303/doc4.xml","form_type":"4"}},{"id":1810875,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-10T20:10:17.000Z","date":"2023-08-09","kind":"exercise","planned":false,"acquired":true,"shares":3571,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":4880,"source":{"system":"sec-edgar","filing":"0001209191-23-045303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123045303/doc4.xml","form_type":"4"}},{"id":1869930,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-02T20:46:38.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":3571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":3571,"derivative":{"underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001209191-23-033841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123033841/doc4.xml","form_type":"4"}},{"id":1869929,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-02T20:46:38.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":false,"shares":297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":298,"derivative":{"underlying":"Common Stock","underlying_shares":297},"source":{"system":"sec-edgar","filing":"0001209191-23-033841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123033841/doc4.xml","form_type":"4"}},{"id":1869928,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T20:46:38.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":true,"shares":297,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1309,"source":{"system":"sec-edgar","filing":"0001209191-23-033841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123033841/doc4.xml","form_type":"4"}},{"id":2189425,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-08-10T20:11:27.000Z","date":"2022-08-09","kind":"grant","acquired":true,"shares":3571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":3571,"derivative":{"underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001209191-22-045188","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919122045188/doc4.xml","form_type":"4"}},{"id":2244758,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-06-03T19:01:33.000Z","date":"2022-06-01","kind":"exercise","acquired":false,"shares":298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":595,"derivative":{"underlying":"Common Stock","underlying_shares":298},"source":{"system":"sec-edgar","filing":"0001209191-22-033924","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919122033924/doc4.xml","form_type":"4"}},{"id":2244757,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T19:01:33.000Z","date":"2022-06-01","kind":"exercise","acquired":true,"shares":298,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1012,"source":{"system":"sec-edgar","filing":"0001209191-22-033924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919122033924/doc4.xml","form_type":"4"}},{"id":2686618,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-06-02T23:34:48.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units (the \"RSUs\") convert into shares of the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":893,"derivative":{"underlying":"Common Stock","underlying_shares":893},"source":{"system":"sec-edgar","filing":"0001019056-21-000358","document":"kunz.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905621000358/kunz.xml","form_type":"4"}},{"id":2686617,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-02T23:34:48.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":2678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":2678,"derivative":{"exercise_price":26.15,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":2678},"source":{"system":"sec-edgar","filing":"0001019056-21-000358","document":"kunz.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905621000358/kunz.xml","form_type":"4"}},{"id":2854812,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-18T02:02:11.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":3571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three approximately equal annual installments beginning on July 2, 2021."}],"balance_after":3571,"derivative":{"exercise_price":9.18,"expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001019056-21-000144","document":"kunz.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905621000144/kunz.xml","form_type":"4"}},{"id":3074046,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-30T01:18:52.000Z","date":"2020-07-27","kind":"grant","acquired":true,"shares":170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant."}],"balance_after":170,"derivative":{"exercise_price":8.56,"expiration_date":"2030-07-26","underlying":"Common Stock","underlying_shares":170},"source":{"system":"sec-edgar","filing":"0001019056-20-000437","document":"kunz.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000437/kunz.xml","form_type":"4"}},{"id":3074045,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-30T01:18:52.000Z","date":"2020-07-27","kind":"grant","acquired":true,"shares":1322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options vest in full on the one year anniversary of the date of grant."}],"balance_after":1322,"derivative":{"exercise_price":8.56,"expiration_date":"2030-07-26","underlying":"Common Stock","underlying_shares":1322},"source":{"system":"sec-edgar","filing":"0001019056-20-000437","document":"kunz.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000437/kunz.xml","form_type":"4"}},{"id":3074044,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-30T01:18:52.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":1785,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options provide for vesting in three approximately equal annual installments beginning on May 31, 2019. Prior to July 27, 2020, all but 595 shares of the issuer's common stock underlying this stock option had vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":76.86,"expiration_date":"2028-06-01","underlying":"Common Stock","underlying_shares":1785},"source":{"system":"sec-edgar","filing":"0001019056-20-000437","document":"kunz.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000437/kunz.xml","form_type":"4"}},{"id":3074043,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-30T01:18:52.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":892,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vested in three approximately equal annual installments beginning on June 1, 2018."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":30.1,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":892},"source":{"system":"sec-edgar","filing":"0001019056-20-000437","document":"kunz.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000437/kunz.xml","form_type":"4"}},{"id":3074042,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-30T01:18:52.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":1339,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vested in three approximately equal annual installments beginning on August 3, 2017."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":41.16,"expiration_date":"2026-08-03","underlying":"Common Stock","underlying_shares":1339},"source":{"system":"sec-edgar","filing":"0001019056-20-000437","document":"kunz.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000437/kunz.xml","form_type":"4"}},{"id":3494299,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false,"officer_title":"Board of Directors"}}],"security":"Common Stock","published_at":"2019-06-11T18:57:17.000Z","date":"2019-06-10","kind":"purchase","acquired":true,"shares":10000,"price":0.8481,"value":8481.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001593968-19-001379","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000159396819001379/primary_01.xml","form_type":"4"}},{"id":3502516,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false,"officer_title":"Board of Directors"}}],"security":"Option (right to buy)","published_at":"2019-06-04T17:00:10.000Z","date":"2019-06-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was granted on June 1, 2019 and becomes exercisable in three equal annual installments beginning on June 1, 2020."}],"balance_after":25000,"derivative":{"exercise_price":0.725,"exercise_date":"2020-06-01","expiration_date":"2029-06-01","underlying":"Aptevo Therapeutics Inc. common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001593968-19-001276","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000159396819001276/primary_01.xml","form_type":"4"}},{"id":3908536,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-04T22:54:59.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on May 31, 2019."}],"balance_after":25000,"derivative":{"exercise_price":5.49,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001019056-18-000786","document":"kunz_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000786/kunz_4.xml","form_type":"4"}},{"id":4298214,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25012,"kind":"person","name":"Kunz Barbara Lopez","position":1,"cik":"0001679970","reported_name":"Kunz Barbara Lopez","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-02T01:39:13.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on June 1, 2018."}],"balance_after":12500,"derivative":{"exercise_price":2.15,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001019056-17-000546","document":"kunz_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000546/kunz_4.xml","form_type":"4"}}]}